Burgy, O.* & Lehmann, M. Small packages but big insights: Extracellular vesicles as biomarkers in interstitial lung disease associated with systemic sclerosis. Eur. Respir. J. 65:2402529 (2025)
Funk, M.C. ; Nawroth, J. & Lehmann, M. A breath of the future: A novel human model for COPD and beyond. Eur. Respir. J. 64:2401531 (2024)
Hu, Y.* et al. Airway derived emphysema-specific alveolar type II cells exhibit impaired regenerative potential in COPD. Eur. Respir. J. 64:2302071 (2024)
Mayr, C. et al. Sfrp1 inhibits lung fibroblast invasion during transition to injury induced myofibroblasts. Eur. Respir. J. 63:2301326 (2024)
Roth, D. et al. Structure-function relationships of mucociliary clearance in human airways. In:. 2024.:PA2654 (Eur. Respir. J. ; 64)
Yildirim, A.Ö. et al. COPD-iNET: A call to the lung community for action to combat the global epidemic of COPD. Eur. Respir. J. 64:2400921 (2024)
Abdo, M.* et al. Minimal clinically important difference for impulse oscillometry in adults with asthma. Eur. Respir. J. 61:2201793 (2023)
Chen, J. et al. Antiviral CD8+T-cell immune responses are impaired by cigarette smoke and in COPD. Eur. Respir. J. 62:16 (2023)
Chen, Y. et al. A spatially resolved extracellular matrix proteome atlas of the distal human lung. Eur. Respir. J. 62:3 (2023)
Conlon, T.M. & Yildirim, A.Ö. Oxysterol metabolism dictates macrophage influx during SARS-CoV-2 infection. Eur. Respir. J. 61:2202417 (2023)
De Sadeleer, L.J. et al. Evolution of epithelial-mesenchymal cell circuits in the progression of pulmonary fibrosis. Eur. Respir. J. 62:2 (2023)
Gote-Schniering, J.* et al. Spatiotemporal analysis of inflammaging and senescence programs in lung fibrosis using time-resolved single-cell transcriptomics and multiplexed immunofluorescence. Eur. Respir. J. 62:OA2624 (2023)
Häfner, F. et al. MRI pulmonary artery flow detects lung vascular pathology in preterms with lung disease. Eur. Respir. J. 62:14 (2023)
He, C. et al. Tropical cyclone and daily respiratory mortality across East Asia: a time series study. Eur. Respir. J. 62:4 (2023)
Kapellos, T. ; Conlon, T.M. ; Yildirim, A.Ö. & Lehmann, M. The impact of the immune system on lung injury and regeneration in COPD. Eur. Respir. J. 62:14 (2023)
Lehmann, M. & Kolb, M.* Another piece in the pirfenidone puzzle. Eur. Respir. J. 61:3 (2023)
Turner, M.C.* et al. Clean air in Europe for all! Taking stock of the proposed revision to the ambient air quality directives: a joint ERS, HEI and ISEE workshop report. Eur. Respir. J. 62:7 (2023)
Zhao, A.* et al. Mortality surrogates in combined pulmonary fibrosis and emphysema. Eur. Respir. J. 63:2300127 (2023)
Bal, C.* et al. Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort. Eur. Respir. J. 59:2101233 (2022)
Habener, A.* et al. IgA+ memory B cells are significantly increased in patients with asthma and small airways dysfunction. Eur. Respir. J. 60:2102130 (2022)
Heinzelmann, K. et al. Single cell RNA sequencing identifies G-protein coupled receptor 87 as a basal cell marker expressed in distal honeycomb cysts in idiopathic pulmonary fibrosis. Eur. Respir. J. 59:2102373 (2022)
Luecken, M. et al. The discovAIR project: A roadmap towards the Human Lung Cell Atlas. Eur. Respir. J. 59:2102057 (2022)
Maison, N. et al. T-high asthma phenotypes across life span. Eur. Respir. J. 60:2102288 (2022)
Schniering, J. ; Maciukiewicz, M.* ; Tanadini-Lang, S.* & Maurer, B.* Reply to: The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis. Eur. Respir. J. 59:2200303 (2022)
Van Eeckhoutte, H.P.* et al. RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD. Eur. Respir. J. 61:2201506 (2022)
van Meel, E.R.* et al. Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: A meta-analysis of 150 000 European children. Eur. Respir. J. 60:2102395 (2022)
Hoeper, M.M.* et al. COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension. Eur. Respir. J. 60:2102311 (2021)
Kammerl, I.E. et al. Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients - implications for therapy. Eur. Respir. J. 59:2101798 (2021)
Lamort, A.-S. et al. Prognostic phenotypes of early-stage lung adenocarcinoma. Eur. Respir. J. 60:2101674 (2021)
Schniering, J. et al. Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis. Eur. Respir. J. 59:2004503 (2021)
Schunk, M.* et al. Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany: A pragmatic fast track randomised controlled trial (BreathEase). Eur. Respir. J. 58:2002139 (2021)
Weckmann, M.* et al. COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy. Eur. Respir. J. 58:2003969 (2021)
Behr, J. et al. Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: Long-term results of the INSIGHTS-IPF registry. Eur. Respir. J. 56:1902279 (2020)
Greiffo, F.R. et al. CX3CR1-fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases. Eur. Respir. J. 55:1900460 (2020)
Kaiser, J.C. & Stathopoulos, G.T. Socioeconomic correlates of SARS-CoV-2 and influenza H1N1 outbreaks. Eur. Respir. J. 56:2001400 (2020)
Morrone, C. et al. Cathepsin B promotes collagen biosynthesis driving Bronchiolitis Obliterans Syndrome. Eur. Respir. J. 57, DOI: 10.1183/13993003.01416-2020 (2020)
Bahmer, T.* et al. miR-122-5p and miR-191-5p are increased in plasma small extracellular vesicles in asthma. Eur. Respir. J. 54 (2019)
Bedard, A.* et al. Is the association between physical activity and lung function due to reverse causation? Application of exploratory and causal approaches. Eur. Respir. J. 54 (2019)
Behr, J.* et al. Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: Long-term results of the INSIGHTS-IPF registry. Eur. Respir. J. 54 (2019)
Chen, J. et al. LSC-2019-Effect of cigarette smoke on immunoproteasome function during virus infection. Eur. Respir. J. 54 (2019)
Fuertes, E.* et al. Lung function up to adolescence and residential greenspace. Eur. Respir. J. 54 (2019)
Gonzalez, E. ; Zhang, X. ; Oak, P. ; Markmann, M.* & Hilgendorff, A.* Hyperoxia exposure induces age-dependent changes in gene expression in healthy mouse lung. Eur. Respir. J. 54 (2019)
Hardy, S. et al. LSC-2019-Validating immunoproteasome activity as a potential biomarker in non-invasive samples from COPD patients. Eur. Respir. J. 54 (2019)
Heinrich, J. et al. Lung function and oral health in adolescents. Eur. Respir. J. 53:1801951 (2019)
Imboden, M.* et al. Epigenome-wide association study of lung function level and its change. Eur. Respir. J. 54, 1-18:1900457 (2019)
Klett-Tammen, C.J.* et al. Quality of life in German GP-Patients with COPD- a longitudinal study. Eur. Respir. J. 54 (2019)
Korfei, M.* et al. Increased susceptibility to gammaherpesvirus-induced lung fibrosis of transgenic mice with conditional overexpression of the ER-stress-factor Chop in alveolar epithelium. Eur. Respir. J. 54 (2019)
Kovacevic, D.* ; Bartel, S.* ; Pfeiffer, S. ; Schloter, M. & Krauss-Etschmann, S.* LSC-2019-The influence of cigarette smoke exposure on the lung and gut microbiome composition in mice. Eur. Respir. J. 54 (2019)
Kreuter, M.* et al. Treatment and survival diversities in different forms of ILD in Germany - EXCITING registry. Eur. Respir. J. 54 (2019)
Kuiper, I.N.* et al. Preconception air pollution exposure and early onset asthma and hay fever in the offspring. Eur. Respir. J. 54 (2019)
Lehmann, M. ; Mutze, K. ; Hu, Q. & Königshoff, M. Late Breaking Abstract - WNT/beta-catenin signaling induces cellular senescence in lung alveolar epithelial cells. Eur. Respir. J. 54 (2019)
Maqhuzu, P.N. ; Schwarzkopf, L. & Kreuter, M.* Healthcare resource utilization and direct costs of interstitial lung disease management in Germany. Eur. Respir. J. 54 (2019)
Markevych, I. et al. Residential greenness and lung function in a prospective cohort of European adults: The ECRHS study. Eur. Respir. J. 54 (2019)
Meul, T. et al. Mitochondrial dysfunction activates MHC class I adaptive immune responses in lung aging. Eur. Respir. J. 54 (2019)
Ramsheh, M.Y.* et al. Prevotella genera abundance in bronchial brush samples differentiates COPD from health and is associated with gene expression. Eur. Respir. J. 54 (2019)
Ramsheh, M.Y.* et al. Association between COPD bronchial brush microbiome-determined ?Proteobacteria:Firmicutes (G:F) ratio and GOLD grade and symptoms. Eur. Respir. J. 54 (2019)
Schultz, K.* et al. Asthma control (AC) and Quality of life (QoL) one year after Pulmonary Rehabilitation (PR). Eur. Respir. J. 54 (2019)
Schwarzkopf, L. ; Witt, S. ; Waelscher, J.* & Kreuter, M.* Longitudinal cost of care in individuals with different subtypes of interstitial lung diseases. Eur. Respir. J. 54 (2019)
Szentes, B.L. et al. Different methods to classify COPD patients into the ABCD severity groups - Preliminary results of the LQ-DMP project. Eur. Respir. J. 54 (2019)
Szentes, B.L. et al. How does EQ-5D-5L perform in asthma patients? Eur. Respir. J. 54 (2019)
Szentes, B.L. et al. Health-related quality of life development in IPF versus other ILD - the HILDA study. Eur. Respir. J. 54 (2019)
Wolff, M.* et al. LSC-2019-Relevant murine model to study the development of COPD pathogenesis in smokers with viral infections. Eur. Respir. J. 54 (2019)
Zhang, X. ; Rodriguez, E. ; Markmann, M.* ; Oak, P. & Hilgendorff, A. Expression profiling of genes differentially regulated under hyperoxia andmechanical ventilation in mouse model of neonatal chronic lung disease. Eur. Respir. J. 54 (2019)
Alter, P.* ; Rabe, K.F.* ; Schulz, H. ; Vogelmeier, C.F.* & Jörres, R.A.* Influence of body mass on predicted values of static hyperinflation in COPD. Eur. Respir. J. 52 (2018)
Byng, D. et al. Identifying predictors of healthcare utilization and costs in COPD patients over 18 months: First longitudinal results of the COSYCONET cohort. Eur. Respir. J. 52 (2018)
Contreras, Z.A.* et al. Does early onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts. Eur. Respir. J. 52:1800504 (2018)
Costa, R. et al. Novel compounds for WNT/beta-catenin induced lung repair in chronic obstructive pulmonary disease. Eur. Respir. J. 52 (2018)
De Santis, M. ; Bolukbas, D.A.* ; Lindstedt, S.* & Wagner, D.E. How to build a lung: Latest advances and emerging themes in lung bioengineering. Eur. Respir. J. 52:1601355 (2018)
De Santis, M.* et al. Development of a hybrid alginate-ECM hydrogel as a potential bioink for 3D bioprinting. Eur. Respir. J. 52 (2018)
Ehrmann, M.* et al. Measurement of volatile organic compounds in exhaled breath of children of the ALL Age Asthma Cohort. Eur. Respir. J. 52 (2018)
Fernandez, I.E. et al. Pharmacometabolic effect of pirfenidone treatment in IPF detected by high resolution MALDI-FTICR imaging. Eur. Respir. J. 52 (2018)
Fernandez, I.E. et al. Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks. Eur. Respir. J. 52 (2018)
Fuertes, E.* et al. Mediation analysis of CRP on the association of physical activity with FEV1 and FVC: The ECRHS study. Eur. Respir. J. 52 (2018)
Garcia, A.D.* et al. Indoor airborne microbiota composition associated with asthma and atopy in rural children. Eur. Respir. J. 52 (2018)
Heinrich, J.* et al. Lung function and oral health in adolescents. Eur. Respir. J. 52 (2018)
Jäger, V. et al. Association between type 2 diabetes, prediabetes and lung function: Results from the KORA cohort. Eur. Respir. J. 52 (2018)
Johannessen, A.* et al. Long-term air pollution exposure is associated with sick leave 20 years later. Eur. Respir. J. 52 (2018)
Karvonen, A.M.* et al. Indoor microbial diversity and risk of different wheezing phenotypes. Eur. Respir. J. 52 (2018)
Kindt-Dunjko, A. et al. Late Breaking Abstract - Protein signature stratifies severity of chronic lung disease in preterms after birth. Eur. Respir. J. 52 (2018)
Knüppel, L. et al. FKBP10 regulates fibroblast migration via synthesis of collagen VI. Eur. Respir. J. 52 (2018)
Kreuter, M.* et al. Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry. Eur. Respir. J. 52 (2018)
Kuiper, I.N.* et al. Lung health in adulthood after childhood exposure to air pollution and greenness. Eur. Respir. J. 52 (2018)
Lambert, K.A.* et al. Associations between early life exposure to pollen and adolescent lung function are modified by residential greenness. Eur. Respir. J. 52 (2018)
Lamort, A. et al. Tumor-derived granulocyte chemotactic protein 2 cooperates with neutrophil proteinase 3 to drive lung adenocarcinoma. Eur. Respir. J. 52 (2018)
Lingner, H.* et al. Describing "real world" COPD patients in primary care in Germany - Findings of the BeoNet-Registry. Eur. Respir. J. 52 (2018)
Pekkanen, J.* et al. Indoor bacteria and asthma in adults: A multicentre case-control study within ECRHS II. Eur. Respir. J. 51:1701241 (2018)
Pepe, M. ; Pelizza, F.* ; Lamort, A. ; Kanellakis, N.I.* & Stathopoulos, G.T. Alteration patterns of tobacco carcinogens in lung adenocarcinoma reveal novel KRAS-addicted candidate oncogenes. Eur. Respir. J. 52 (2018)
Peralta, G.P.* et al. Body mass index trajectories during adult life and lung function decline. Eur. Respir. J. 52 (2018)
Real, F.G.* et al. Maternal age at delivery, lung function and asthma in offspring: A population-based survey. Eur. Respir. J. 51:1601611 (2018)
Russell, M.* et al. The association of vigorous physical activity with 10-year adult asthma incidence. Eur. Respir. J. 52 (2018)
Schroeder, A.S.* et al. IL-37 ameliorates experimental asthma by inhibiting IL-1. Eur. Respir. J. 52 (2018)
Schultz, K.* et al. Effectiveness of pulmonary Rrhabilitation for patients with asthma: EPRA-RCT. Eur. Respir. J. 52 (2018)
Schwarzkopf, L. ; Witt, S. ; Waelscher, J.* ; Polke, M.* & Kreuter, M.* Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis. Eur. Respir. J. 52 (2018)
Schwarzkopf, L. & Murawski, M. Survival impact of comorbidity in German Lung Cancer patients - a claims data-based 'Comorbidome'. Eur. Respir. J. 52 (2018)
Sun, N. et al. Pharmacometabolic response to pirfenidone in pulmonary fibrosis detected by MALDI-FTICR-MSI. Eur. Respir. J. 52:1702314 (2018)
Szentes, B.L. et al. Suitable questionnaires to measure quality of life in patients with asthma bronchial undergoing pulmonary rehabilitation. Eur. Respir. J. 52 (2018)
Walter, J. ; Holle, R. ; Tufman, A.* & Schwarzkopf, L. Changes in targeted therapy and costs in NSCLC between 2009 and 2013. Eur. Respir. J. 52 (2018)
Wartenberg, M.* et al. Cigarette smoke induces overexpression of cathepsin S in active smokers with and without COPD. Eur. Respir. J. 52 (2018)
Welk, V. et al. Analyzing the role of proteasome activator 200 (PA200) in lung cancer. Eur. Respir. J. 52 (2018)
Witt, S. ; Waelscher, J.* ; Schwarzkopf, L. & Kreuter, M.* Hospitalisation pattern in Interstitial Lung Diseases: A claims data study. Eur. Respir. J. 52 (2018)
Witt, S. et al. Medication for childhood interstitial lung diseases differs internationally. Eur. Respir. J. 52 (2018)
Burgstaller, G. et al. The instructive extracellular matrix of the lung: Basic composition and alterations in chronic lung disease. Eur. Respir. J. 50:1601805 (2017)
Ekström, M.* et al. Absolute values of lung function explain the sex difference in breathlessness in the general population. Eur. Respir. J. 49:1602047 (2017)
Flexeder, C. et al. Higher serum 25(OH)D concentrations are associated with improved FEV1 and FVC in adolescence. Eur. Respir. J. 49:1601804 (2017)
Kneidinger, N.* et al. Lung volumes predict survival in patients with chronic lung allograft dysfunction. Eur. Respir. J. 49:1601315 (2017)
Lehmann, M. et al. Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo. Eur. Respir. J. 50:1602367 (2017)
Taggart, C.* et al. Protean proteases: At the cutting edge of lung diseases. Eur. Respir. J. 49:1501200 (2017)
Thurston, G.D.* et al. A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework. Eur. Respir. J. 49:1600419 (2017)
Fernandez, I.E. et al. Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis. Eur. Respir. J. 48, 1171-1183 (2016)
Förster, K. et al. LSC Abstract – Early biomarkers indicating the development of neonatal chronic lung disease defined by clinical and imaging parameters. Eur. Respir. J. 48, PP104 (2016)
Horowitz, J.C.* ; Osterholzer, J.J.* ; Marazioti, A.* & Stathopoulos, G.T. "Scar-cinoma": Viewing the fibrotic lung mesenchymal cell in the context of cancer biology. Eur. Respir. J. 47, 1842-1854 (2016)
Samoli, E.* et al. Exposure to ultrafine particles and respiratory hospitalisations in five European cities. Eur. Respir. J. 48, 674-682 (2016)
Smith, M. et al. Physical activity is not associated with spirometric indices in lung-healthy German youth. Eur. Respir. J. 48, 428-440 (2016)
Subramanian, D.R.* et al. Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography. Eur. Respir. J. 48, 92-103 (2016)
Vardavas, C.I.* et al. The independent role of prenatal and postnatal exposure to active and passive smoking on the development of early wheeze in children. Eur. Respir. J. 48, 115-124 (2016)
Aanerud, M.* et al. Interaction between asthma and smoking increases the risk of adult airway obstruction. Eur. Respir. J. 45, 635-643 (2015)
Adam, M.* et al. Adult lung function and long-term air pollution exposure. ESCAPE: A multicentre cohort study and meta-analysis. Eur. Respir. J. 45, 38-50 (2015)
Behr, J. et al. Management of patients with idiopathic pulmonary fibrosis in clinical practice: The INSIGHTS-IPF registry. Eur. Respir. J. 46, 186-196 (2015)
de Marco, R.* et al. Asthma, COPD and overlap syndrome: A longitudinal study in young European adults. Eur. Respir. J. 46, 671-679 (2015)
Meiners, S. ; Eickelberg, O. & Königshoff, M. Hallmarks of the ageing lung. Eur. Respir. J. 45, 807-827 (2015)
Mölter, A.* et al. A multicentre study of air pollution exposure and childhood asthma prevalence: The ESCAPE project. Eur. Respir. J. 45, 610-624 (2015)
Tischer, C.G. et al. Early exposure to bio-contaminants and asthma up to 10 years of age: Results of the HITEA study. Eur. Respir. J. 54, 328-337 (2015)
Tischer, C.G. et al. Sleeping on animal fur is related to asthma outcomes in later childhood. Eur. Respir. J. 46, 107-114 (2015)
Uhl, F. et al. Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures. Eur. Respir. J. 46, 1150-1166 (2015)
Albrecht, E. et al. Telomere length in circulating leukocytes is associated with lung function and disease. Eur. Respir. J. 43, 983-992 (2014)
Bousquet, J.* et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur. Respir. J. 44, 304-323 (2014)
Gallmeier, K. et al. Prediction of new-onset asthma and nasal allergy by skin prick test and RAST in a cohort of adults. Eur. Respir. J. 43, 92-102 (2014)
Husemann, K.* et al. Double tracer gas single-breath washout: Reproducibility in healthy subjects and COPD. Eur. Respir. J. 44, 1210-1222 (2014)
Königshoff, M. The new Back to Basics section: Emerging concepts in basic and translational medicine. Eur. Respir. J. 44, 297-298 (2014)
Meiners, S. & Greene, C.M.* Protein quality control in lung disease: It's all about cloud networking. Eur. Respir. J. 44, 846-849 (2014)
Schikowski, T.* et al. Association of ambient air pollution with the prevalence and incidence of COPD. Eur. Respir. J. 44, 614-626 (2014)
Siroux, V.* et al. Genetic heterogeneity of asthma phenotypes identified by a clustering approach. Eur. Respir. J. 43, 439-452 (2014)
van Rijt, S.H. ; Bein, T.* & Meiners, S. Medical nanoparticles for next generation drug delivery to the lungs. Eur. Respir. J. 44, 765-774 (2014)
Baarsma, H.A. & Koenigshoff, M. WNT5A antagonizes canonical WNT/beta-catenin signaling in lung epithelial cells. Eur. Respir. J. 42 (2013)
Bartel, S. et al. miRNA-based identification of SEC14L3 deregulation in murine experimental asthma. Eur. Respir. J. 42 (2013)
Bartmann, J. ; Frankenberger, M. ; Neurohr, C.* ; Eickelberg, O. & von Wulffen, W.* Prominence of MMP-12 and MMP-13 in dendritic cells and the impact on a murine model of bronchiolitis obliterans. Eur. Respir. J. 42 (2013)
Blume, C.* et al. Barrier responses of human bronchial epithelial cells to grass pollen exposure. Eur. Respir. J. 42, 87-97 (2013)
Canova, C.* et al. The influence of sensitisation to pollens and moulds on seasonal variations in asthma attacks. Eur. Respir. J. 42, 935-945 (2013)
Dehmel, S. et al. Characterization of Tbx21-deficient mice as a model for transgenerational asthma risk propagation. Eur. Respir. J. 42 (2013)
Fernandez, I.E. ; Amarie, O.V. ; Yildirim, O. ; Koenigshoff, M. & Eickelberg, O. Novel biomarkers in bleomycin-induced pulmonary fibrosis. Eur. Respir. J. 42 (2013)
Gimm, T. ; Kossert, M.* ; Alvira, C.M.* ; Ehrhardt, H.* & Hilgendorff, A.* Role of TNF-a in ventilator-induced lung injury in the developing murine lung. Eur. Respir. J. 42 (2013)
Gimm, T. et al. Identification of biomarkers for early diagnosis in BPD. Eur. Respir. J. 42 (2013)
Hilgendorff, A.* et al. Increased risk for lung injury in PDGF-R alpha deficient newborn mice. Eur. Respir. J. 42 (2013)
Jia, J. ; Eickelberg, O. & Yildirim, A.Ö. Cigarette smoke induced Muc5AC is regulated by CARM1 in an ex-vivo airway model. Eur. Respir. J. 42 (2013)
Keller, I.E. et al. Immunoproteasome expression in pulmonary fibrosis. Eur. Respir. J. 42 (2013)
Königshoff, M. ; Saglani, S.* ; Marsland, B.J.* & Eickelberg, O. Rebuilding a diseased lung: Repair and regeneration. Eur. Respir. J. 41, 497-499 (2013)
Korfei, M.* et al. Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP). Eur. Respir. J. 42 (2013)
Lenz, A.-G. et al. Fast, efficient and realistic in vitro delivery of inhaled drugs to pulmonary cells: Application to the proteasome inhibitor bortezomib. Eur. Respir. J. 42 (2013)
Milger, K. ; Eickelberg, O. ; Krauss-Etschmann, S. & Dehmel, S. MicroRNA based biomarkers for early risk assessment of asthma. Eur. Respir. J. 42 (2013)
Möller, W. et al. Nasal high flow clears dead space in healthy volunteers and in an in vitro upper airway model. Eur. Respir. J. 42 (2013)
Mossina, A. et al. Proteomic profiling of alveolar epithelial cells exposed to cigarette smoke extract. Eur. Respir. J. 42 (2013)
Pfister, N. ; Eickelberg, O. & Meiners, S. Proteasome function in lung fibrosis. Eur. Respir. J. 42 (2013)
Raghu, G.* et al. Macitentan for the treatment of idiopathic pulmonary fibrosis: The randomised controlled MUSIC trial. Eur. Respir. J. 42, 1622-1632 (2013)
Sarker, R.S.J. et al. Involvement of coactivator associated arginine methyltransferase 1 (CARM1) in development of elastase-induced progressive emphysema. Eur. Respir. J. 42 (2013)
Schulz, H. et al. Telomere length in circulating leukocytes is associated with lung function and disease. Eur. Respir. J. 42 (2013)
Annesi-Maesano, I.* ; Heinrich, J. ; Ayres, J.G.* & Forastiere, F.* Why an ERJ series on air pollution? Eur. Respir. J. 40, 12-13 (2012)
Bakolis, I.* et al. Respiratory health and endotoxin: Associations and modification by CD14/-260 genotype. Eur. Respir. J. 39, 573-581 (2012)
Ghosh, D.* ; Rzehak, P. ; Elliott, M.W.* & Windisch, W.* Validation of the English severe respiratory insufficiency questionnaire. Eur. Respir. J. 40, 408-415 (2012)
Gläser, S.* et al. Airflow limitation, lung volumes and systemic inflammation in a general population. Eur. Respir. J. 39, 29-37 (2012)
Hoek, G.* et al. PM10 and children's respiratory symptoms and lung function in the PATY study. Eur. Respir. J. 40, 538-547 (2012)
Kormann, M.S.* et al. CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung disease. Eur. Respir. J. 39, 1385-1390 (2012)
Meiners, S. & Eickelberg, O. What shall we do with the damaged proteins in lung disease? Ask the proteasome! Eur. Respir. J. 40, 1260-1268 (2012)
Ziegler-Heitbrock, L. et al. The EvA study: Aims and strategy. Eur. Respir. J. 40, 823-829 (2012)
European IPF Network (Günther, A.* ; Eickelberg, O.) & The European IPF Network The European IPF Network: Towards better care for a dreadful disease. Eur. Respir. J. 37, 747-748 (2011)
Marsland, B.J.* ; Königshoff, M. ; Saglani, S.* & Eickelberg, O. Immune system dysregulation in chronic lung disease. Eur. Respir. J. 38, 500-501 (2011)
Pfaff, E.-M.* ; Becker, S.* ; Günther, A.* & Königshoff, M. Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis. Eur. Respir. J. 37, 79-87 (2011)
Rebordosa, C.* et al. ADRB2 Gly16Arg polymorphism, asthma control and lung function decline. Eur. Respir. J. 38, 1029-1035 (2011)
Seifart, C.* et al. ATRA results in irregular repair of septa and fails to inhibit proinflammatory macrophages. Eur. Respir. J. 38, 425-439 (2011)
Tischer, C.G. et al. Respiratory health in children, and indoor exposure to (1,3)-β-D-glucan, EPS mould components and endotoxin. Eur. Respir. J. 37, 1050-1059 (2011)
Tischer, C.G. ; Chen, C.-M. & Heinrich, J. Association between domestic mould and mould components, and asthma and allergy in children: A systematic review. Eur. Respir. J. 38, 812-824 (2011)
Brain, J.D.* ; Kreyling, W.G. & Gehr, P.* Comment on: Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur. Respir. J. 35, 226-227 (2010)
Eickelberg, O. ; Laurent, G.* ; Nicod, L.P.* ; Hartl, S.* & Siafakas, N.M.* European Respiratory Society MD PhD programme in respiratory science. Eur. Respir. J. 36, 229-230 (2010)
Moshammer, H.* et al. Gas cooking is associated with small reductions in lung function in children. Eur. Respir. J. 36, 249-254 (2010)
Castro-Giner, F.* et al. Joint effect of obesity and TNFA variability on asthma: Two international cohort studies. Eur. Respir. J. 33, 1003-1009 (2009)
Cerveri, I.* et al. What defines airflow obstruction in asthma? Eur. Respir. J. 34, 568-573 (2009)
Dharmage, S.C.* et al. Do childhood respiratory infections continue to influence adult respiratory morbidity? Eur. Respir. J. 33, 237-244 (2009)
Frankenberger, M. et al. Inhaled all-trans retinoic acid in an individual with severe emphysema. Eur. Respir. J. 34, 1487-1489 (2009)
Jacquemin, B.* et al. Association between modelled traffic-related air pollution and asthma score in the ECRHS. Eur. Respir. J. 34, 834-842 (2009)
Castro-Giner, F.* et al. TNFA -308G>A in two international population-based cohorts and risk of asthma. Eur. Respir. J. 32, 350-361 (2008)
Chen, C.M. et al. Dog ownership and contact during childhood and later allergy development. Eur. Respir. J. 31, 963-973 (2008)
Kraetzel, K.* et al. NKG2D-dependent effector function of bronchial epithelium activated alloreactive T cells. Eur. Respir. J. 32, 1-8 (2008)
Sunyer, J.* et al. Systemic inflammation, genetic susceptibility and lung function. Eur. Respir. J. 32, 92-97 (2008)
Weinmayr, G.* et al. International variation in prevalence of rhinitis and its relationship with sensitisation to perennial and seasonal allergens. Eur. Respir. J. 32, 1250-1261 (2008)
Gehring, U. et al. Bacteria and mould components in house dust and children's allergic sensitisation. Eur. Respir. J. 29, 1144-1153 (2007)
Schulze, A. ; van Strien, R.T.* ; Praml, G.* ; Nowak, D.* & Radon, K.* Characterisation of asthma among adults with and without childhood farm contact. Eur. Respir. J. 29, 1169-1173 (2007)
André, E. et al. Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung. Eur. Respir. J. 28, 275-285 (2006)
Gehring, U. et al. Parental education and children's respiratory and allergic symptoms in the pollution and the young (PATY) study. Eur. Respir. J. 27, 95-107 (2006)
Janson, C.* et al. Changes in active and passive smoking in the European community respiratory health survey. Eur. Respir. J. 27, 517-524 (2006)
Wiebert, P.* et al. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur. Respir. J. 28, 286-290 (2006)
Kauffmann, F.* & Post Genome Respiratory Epidemiology Group (Wjst, M.) Post-genome respiratory epidemiology: A multidisciplinary challenge. Eur. Respir. J. 24, 471-480 (2004)
Trak-Fellermeier, M.A. ; Brasche, S.* ; Winkler, G.* ; Koletzko, B.* & Heinrich, J. Food and fatty acid intake and atopic disease in adults. Eur. Respir. J. 23, 575-582 (2004)
Brand, P. et al. Peripheral deposition alpha1-protease inhibitor using commercial inhalation devices. Eur. Respir. J. 22, 263-267 (2003)
Heinrich, J. Nonallergic respiratory morbidity improved along with a decline of traditional air pollution levels : A review. Eur. Respir. J. 21, 40, 64-69 (2003)
Neurohr, C.* et al. Glutamate-cysteine ligase modulatory subunit in BAL alveolar macrophages of healthy smokers. Eur. Respir. J. 22, 82-87 (2003)
Gehring, U. et al. Traffic-related air pollution and respiratory health during the first 2 yrs of life. Eur. Respir. J. 19, 690-698 (2002)
Heinrich, J. et al. Trends in prevalence of atopic diseases and allergic sensitization in children in Eastern Germany. Eur. Respir. J. 19, 1040-1046 (2002)
Heinrich, J. et al. Allergens and endotoxin on mothers mattresses and total immunoglobulin E in cord blood neonates. Eur. Respir. J. 20, 617-623 (2002)
von Klot, S. et al. Increased asthma medication use in association with ambient fine and ultrafine particles. Eur. Respir. J. 20, 691-702 (2002)
Janson, C.* et al. The European Community Respiratory Health Survey: What are the main results so far? European Community Respiratory Health Survey II. Eur. Respir. J. 18, 598-611 (2001)
Schmitz, T.* ; von Kries, R.* ; Wjst, M. & Schuster, A.* A nationwide survey in Germany on fatal asthma and near-fatal asthma in children: different entities ?. Eur. Respir. J. 16, 845-849 (2000)
Lenz, A.-G. et al. Oxidatively modified proteins in bronchoalveolar lavage fluid of patients with ARDS and patients at-risk for ARDS. Eur. Respir. J. 13, 169-174 (1999)
Lenz, A.-G. ; Costabel, U. & Maier, K.L. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur. Respir. J. 9, 307-312 (1996)
Brand, P. et al. Detection of early lung impairment with aerosol bolus dispersion. Eur. Respir. J. 7, 1830-1838 (1994)
Maier, K.L. How the lung deals with oxidants. Eur. Respir. J. 6, 334-336 (1993)
Maier, K.L. ; Leuschel, L. & Costabel, U. Increased oxidized methionine residues in BAL fluid proteins in acute or chronic bronchitis. Eur. Respir. J. 5, 651-658 (1992)